Alekseev B N, Pisetskaia S F, Pereverzina O K
Vestn Oftalmol. 1990 Nov-Dec;106(6):23-6.
The authors analyze the results of treatment of 30 eyes of 28 patients suffering from various forms of diabetes mellitus for 1 to 15 years; no cases with neovascularization or proliferative diabetic retinopathy were included in the study. Extracapsular cataract extraction with intraocular lens (IOL) intracapsular implantation was carried out according to the method developed by B. N. Alexeyev. Polymethylmethacrylate lens with a 5 mm diameter of the optic section with polymethylmethacrylate supporting elements was implanted into the capsular sac. In 4 cases lenses with 7 mm optic section diameter and with polypropylene supporting arches were implanted. IOLs were implanted in both eyes to 2 patients. The methods of examination included visometry, biomicroscopy, measurements of the blood sugar before and after surgery, tonometry, tonography, echography, ophthalmometry, gonioscopy, fluorescent angiography. The findings permit a conclusion that IOL intracapsular implantation to diabetics was effective in all 30 cases analyzed. High visual acuity was achieved in more than 80 percent of patients. No grave complications of the ocular or general condition due to diabetes mellitus were recorded. Therefore IOL intracapsular implantation is safe and possible in type I and II diabetes mellitus patients.
作者分析了28例患有各种类型糖尿病1至15年的患者的30只眼睛的治疗结果;研究未纳入新生血管形成或增殖性糖尿病视网膜病变的病例。根据B. N. 阿列克谢耶夫开发的方法进行了白内障囊外摘除联合人工晶状体(IOL)囊内植入。将光学部分直径为5 mm且带有聚甲基丙烯酸甲酯支撑元件的聚甲基丙烯酸甲酯晶状体植入囊袋内。4例患者植入了光学部分直径为7 mm且带有聚丙烯支撑弓的晶状体。2例患者双眼植入了人工晶状体。检查方法包括视力测量、生物显微镜检查、手术前后血糖测量、眼压测量、眼压描记、超声检查、眼球测量、前房角镜检查、荧光血管造影。研究结果表明,在分析的所有30例病例中,糖尿病患者的人工晶状体囊内植入是有效的。超过80%的患者获得了高视力。未记录到因糖尿病导致的严重眼部或全身并发症。因此,I型和II型糖尿病患者进行人工晶状体囊内植入是安全可行的。